The coming-of-age of pharmacogenetic testing in clinical psychiatry

Psychiatry Clin Neurosci. 2019 May;73(5):203. doi: 10.1111/pcn.12832.

Authors

Kazunari Yoshida^{1

2

3}, Daniel J Müller^{1

3

4}, James L Kennedy^{1

3

4}

Affiliations

¹ Pharmacogenetic Research Clinic, Centre for Addiction and Mental Health, Toronto, Canada.
² Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
³ Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
⁴ Departments of Psychiatry and Institute of Medical Science, University of Toronto, Toronto, Canada.

PMID: 31045316
DOI: 10.1111/pcn.12832

No abstract available

Publication types

Editorial

MeSH terms

Humans
Mental Disorders / drug therapy*
Mental Disorders / genetics
Pharmacogenomic Testing / methods*
Pharmacogenomic Testing / standards
Psychiatry / methods*
Psychiatry / standards